SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 273 filers reported holding SEATTLE GENETICS INC in Q4 2016. The put-call ratio across all filers is 2.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $27,799,000 | +38.9% | 526,785 | +42.1% | 0.03% | +33.3% |
Q3 2016 | $20,018,000 | +33.2% | 370,627 | -0.3% | 0.02% | +40.0% |
Q2 2016 | $15,023,000 | +15.6% | 371,755 | +0.4% | 0.02% | +7.1% |
Q1 2016 | $12,995,000 | +4.1% | 370,334 | +33.1% | 0.01% | +7.7% |
Q4 2015 | $12,488,000 | +34.9% | 278,255 | +15.9% | 0.01% | +30.0% |
Q3 2015 | $9,258,000 | -17.3% | 240,099 | +3.9% | 0.01% | -16.7% |
Q2 2015 | $11,188,000 | +36.9% | 231,156 | 0.0% | 0.01% | +50.0% |
Q1 2015 | $8,171,000 | +10.0% | 231,156 | 0.0% | 0.01% | +14.3% |
Q4 2014 | $7,427,000 | -73.6% | 231,156 | -69.4% | 0.01% | -75.0% |
Q3 2014 | $28,123,000 | -48.4% | 756,401 | -46.9% | 0.03% | -46.2% |
Q2 2014 | $54,476,000 | -16.2% | 1,424,197 | -0.2% | 0.05% | -18.8% |
Q1 2014 | $64,984,000 | +0.6% | 1,426,337 | -11.9% | 0.06% | +3.2% |
Q4 2013 | $64,603,000 | -27.0% | 1,619,546 | -19.8% | 0.06% | -30.3% |
Q3 2013 | $88,491,000 | +26.0% | 2,018,966 | -9.5% | 0.09% | +20.3% |
Q2 2013 | $70,212,000 | – | 2,231,771 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lagoda Investment Management, L.P. | 57,170 | $10,013,000 | 5.39% |
Boxer Capital, LLC | 400,000 | $70,056,000 | 2.25% |
PARTNERS CAPITAL INVESTMENT GROUP, LLP | 110,153 | $19,292,000 | 1.10% |
DCF Advisers, LLC | 13,300 | $2,329,000 | 0.96% |
XTX MARKETS LLC | 2,418 | $423,000 | 0.87% |
FAIRFIELD, BUSH & CO. | 15,035 | $2,633,000 | 0.77% |
Parcion Private Wealth LLC | 4,520 | $792,000 | 0.10% |
Gulf International Bank (UK) Ltd | 26,091 | $4,569,000 | 0.06% |
Princeton Portfolio Strategies Group LLC | 1,500 | $263,000 | 0.05% |
Redpoint Investment Management Pty Ltd | 2,392 | $419,000 | 0.04% |